Brryh, From what I remember the protection will last until the end of 2037. ATH has also patents for new zinc chelators for the same purpose as PBT2 but clinical evidence has not been demonstrated for them.
Ann: Presentation of bioMUSE Data at the AAN Annual Meeting, page-11
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $6.732K | 2.155M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 17158898 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130236053 | 30 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |